CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets (12.5mg Empagliflozin / 1000mg Metformin HCl) Versus Synjardy® 12.5mg/1000mg Film-coated Tablets (12.5mg Empagliflozin/ 1000mg Metformin HCl) in Healthy Subjects Under Fed Conditions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06450262
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:27.964274+00:00
Published At: 2024-06-10T00:00:00+00:00
Record Updated At: 2024-06-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Type2diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-06-10"
protocolSection.identificationModule.nctId: "NCT06450262"
protocolSection.identificationModule.officialTitle: "Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets (12.5mg Empagliflozin / 1000mg Metformin HCl) Versus Synjardy\u00ae 12.5mg/1000mg Film-coated Tablets (12.5mg Empagliflozin/ 1000mg Metformin HCl) in Healthy Subjects Under Fed Conditions"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.